Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease

Medical Clinics of North America

Volumn 84, Issue 1, 2000, Pages 163-179

  Bhatt, Deepak L ^b   Topol, Eric J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DALTEPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; ORBOFIBAN; SIBRAFIBAN; TICLOPIDINE; WARFARIN; XEMILOFIBAN;

ANTICOAGULANT THERAPY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG POTENCY; DRUG TOLERABILITY; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0033983526     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70212-1     Document Type: Article

References (96)